Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class ITerminatedJun 1, 2016Shorts on The Beach Golden Edition by Pink BikiniMarketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.Lucy's Weight Loss (dba. Waisted With Lucy) · D-0881-2016Class ITerminatedJun 1, 2016Shorts on The Beach Strong Formula by Pink Bikini capsulesMarketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.Lucy's Weight Loss (dba. Waisted With Lucy) · D-0880-2016Class ITerminatedJun 1, 2016Pink Bikini Strong Formula capsulesMarketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.Lucy's Weight Loss (dba. Waisted With Lucy) · D-0879-2016Class ITerminatedJun 1, 2016Smart Lipo Dietary Supplement capsulesMarketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.Centro Naturista · D-0878-2016Class ITerminatedJun 1, 2016Smart Lipo Dietary Supplement capsulesMarketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.Centro Naturista · D-0877-2016Class IITerminatedJun 1, 2016PerioRxFailed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.Akorn, Inc. · D-0876-2016Class IITerminatedJun 1, 2016Chlorhexidine gluconateFailed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.Akorn, Inc. · D-0875-2016Class IITerminatedJun 1, 2016ORIS (chlorhexidine gluconate)Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.Akorn, Inc. · D-0874-2016Class ITerminatedJun 1, 2016Auvi-Q (epinephrine injectionDefective Delivery System; potential to have inaccurate dosage deliverySanofi-Aventis U.S. LLC · D-0873-2016Class ITerminatedJun 1, 2016Auvi-Q (epinephrine injectionDefective Delivery System; potential to have inaccurate dosage deliverySanofi-Aventis U.S. LLC · D-0872-2016Class ITerminatedJun 1, 2016Morphine Sulfate 0.5 mg/mLSuper-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.Pharmakon Pharmaceuticals · D-0871-2016Class ITerminatedJun 1, 2016AvastinNon-Sterility: Product tested positive for bacterial contamination.Pacifico National, Inc. dba AmEx Pharmacy · D-0870-2016Class ITerminatedJun 1, 2016AvastinNon-Sterility: Product tested positive for bacterial contamination.Pacifico National, Inc. dba AmEx Pharmacy · D-0869-2016Class IITerminatedJun 1, 2016Linezolid InjectionLack of Assurance of Sterility: Due to potential for leaking bags.Teva North America · D-0868-2016Class IITerminatedJun 1, 2016OCTREOTIDE ACETATE INJECTIONFailed Impuities/Degradation SpecificationsFresenius Kabi USA, LLC · D-0867-2016Class IITerminatedJun 1, 2016OCTREOTIDE ACETATE INJECTIONFailed Impuities/Degradation SpecificationsFresenius Kabi USA, LLC · D-0866-2016Class IOngoingJun 1, 20168.4% Sodium Bicarbonate InjectionPresence of Particulate Matter: particulate matter identified as an insect in one vial.Hospira Inc. · D-0865-2016Class ITerminatedJun 1, 2016CLINIMIX E 5/15 sulfite-freePresence of Particulate Matter: identified as dried skin.Baxter Healthcare Corp. · D-0864-2016Class ITerminatedJun 1, 2016Metronidazole Injection USPPresence of Particulate Matter: identified as a cloth fiber.Baxter Healthcare Corp. · D-0863-2016Class ITerminatedJun 1, 20160.9% Sodium Chloride Injection USPPresence of Particulate Matter: identified as cardboard.Baxter Healthcare Corp. · D-0862-2016Class IITerminatedJun 1, 20160.9% Sodium Chloride Injection USPLack of Assurance of Sterility: potential for leaking containers which lacks the assurance of sterility.Baxter Healthcare Corp. · D-0861-2016Class ITerminatedJun 1, 2016LIPO ESCULTURA capsulesMarketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was...Lipo Escultura Corp. · D-0860-2016Class ITerminatedJun 1, 2016Amikacin Sulfate injection USPPresence of Particulate Matter: particulate matter identified as glass in one vial.Teva Pharmaceuticals USA · D-0859-2016Class IITerminatedJun 1, 2016Sclerosol Intrapleural AerosolDefective Delivery System: Defective stem valve causes leakage of the propellant in the spray canister delivering no drug or an inadequate amount of the drug to be...Lymol Medical · D-0858-2016Class IITerminatedJun 1, 2016Zoloft (sertraline HCl) tabletsFailed Tablet/Capsule Specifications: thick tablets exceeding specifications were found.Pfizer Inc. · D-0857-2016Class IIITerminatedMay 25, 2016col-riteSuperpotent Drug: High out of specification results for assay at the 6 month time point interval.Allegiant Health · D-0856-2016Class IITerminatedMay 25, 2016Renovo PatchMarketed Without An Approved NDA/ANDA: product is an unapproved drug and additionally 3 lots were found to be subpotent.TMIG Inc · D-0855-2016Class IIIOngoingMay 25, 2016Magnesium Sulfate InjFailed pH Specifications: Confirmed high out of specification (OOS) results for pH.Hospira Inc. · D-0854-2016Class IITerminatedMay 25, 2016BETTER BRAIDS UN-BRAIDMicrobial Contamination of Non-Sterile Products: Failed S.aureus test.Keystone Laboratories Inc · D-0853-2016Class IITerminatedMay 18, 2016Brevibloc DOUBLE STRENGTH Premixed InjectionDiscoloration: presence of atypical yellow discoloration of the solution .Baxter Healthcare Corp. · D-0852-2016Class IIOngoingMay 18, 2016Screenses Color SunscreencGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0851-2016Class IIOngoingMay 18, 2016Screenses Color Sunscreen Tinted facial make-up compactcGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0850-2016Class IIOngoingMay 18, 2016Repaskin 30cGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0849-2016Class IIOngoingMay 18, 2016Repaskin 50cGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0848-2016Class IIOngoingMay 18, 2016Dryses Aluminum Chlorohydrate Deodorant for WomencGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0847-2016Class IIOngoingMay 18, 2016Dryses Aluminum Chlorohydrate Deodorant for Men Roll-oncGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0846-2016Class IIOngoingMay 18, 2016Repaskin 30cGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0845-2016Class IIOngoingMay 18, 2016Repaskin 50cGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0844-2016Class IIOngoingMay 18, 2016Salises Facial Moisturizing Acne Treatment GelcGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0843-2016Class IIOngoingMay 18, 2016Dryses Aluminum Chlorohydrate Antiperspirant SolutioncGMP Deviations; product does not comply with cGMP requirementsSesderma, SL · D-0842-2016